organization dedicated to the natural products industry
Lobbied in support of a Congressional sign-on letter to the Internal Revenue Service asking them to revise IRS Publication 502 to allow nutritional and dietary supplements that carry health claims or structure/function claims to be considered medical expenses. 

Lobbied on the need for the Food and Drug Administration to create a system for greater communication between the New Dietary Ingredient (NDI) and Generally Recognized as Safe (GRAS) review programs at the U.S. Food and Drug Administration (FDA).

Lobbied on the need for CBD regulations at the Food and Drug Administration (no specific bill)
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE KEELEN GROUP, LLC
PO Box 2016, Arlington, VA, 22202, US
MATTHEW B KEELEN